Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient`s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.
Website: inspiresleep.com



Growth: Good revenue growth rate 39.9%, there is slowdown compared to average historical growth rates 80.1%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of -4.4%

Profitability: LTM EBITDA margin is negative, -5.9%. On average the margin is improving steadily. Gross margin is high, +85.4%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.25 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -4.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 83.7% higher than minimum and 29.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 4.7x by EV / Sales multiple , the company can be 55.4% overvalued

Insiders: For the last 3 months insiders sold company shares on $17.3 mln (-0.290% of cap.)

Key Financials (Download financials)

Ticker: INSP
Share price, USD:  (-1.8%)230.05
year average price 222.81  


year start price 268.78 2023-04-27

max close price 326.08 2023-07-14

min close price 125.26 2023-11-13

current price 230.05 2024-04-25
Common stocks: 29 517 375

Dividend Yield:  0.0%
Last revenue growth (y/y):  39.9%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  80.1%
Historical growth of EBITDA:  ---
EV / Sales: 10.6x
Margin (EBITDA LTM / Revenue): -5.9%
Fundamental value created in LTM:
Market Cap ($m): 6 790
Net Debt ($m): -161
EV (Enterprise Value): 6 629
Price to Book: 12.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-18Zacks Investment Research

Why You Should Add Inspire Medical (INSP) to Your Portfolio

2024-04-18Zacks Investment Research

Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains?

2024-04-09Zacks Investment Research

New Strong Buy Stocks for April 9th

2024-03-18Zacks Investment Research

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

2024-02-06Zacks Investment Research

Compared to Estimates, Inspire (INSP) Q4 Earnings: A Look at Key Metrics

2024-02-06Zacks Investment Research

Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates

2024-02-06Seeking Alpha

Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript

2024-01-09Zacks Investment Research

Inspire Medical (INSP) Reports Solid Preliminary Q4 Revenues

2023-12-29Zacks Investment Research

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

2023-12-07Zacks Investment Research

Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-09 2023-11-07 2023-08-01 2023-05-02 2023-02-10 2022-11-01
acceptedDate 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 193M 153M 151M 128M 138M 109M
costOfRevenue 28M 24M 24M 20M 22M 20M
grossProfit 164M 129M 127M 108M 116M 89M
grossProfitRatio 0.854 0.841 0.839 0.844 0.839 0.819
researchAndDevelopmentExpenses 31M 29M 31M 26M 21M 21M
generalAndAdministrativeExpenses 98M 88M 0 0 0 0
sellingAndMarketingExpenses 26M 26M 0 0 0 0
sellingGeneralAndAdministrativeExpenses 124M 113M 113M 102M 95M 86M
otherExpenses 73 000 -224 000 -61 000 17 000 241 000 0
operatingExpenses 155M 142M 143M 128M 116M 107M
costAndExpenses 183M 167M 168M 147M 138M 126M
interestIncome 6M 5M 5M 4M 3M 1M
interestExpense 0 0 0 -4M -569 000 656 000
depreciationAndAmortization 817 000 5M 659 000 4M 569 000 2M
ebitda 16M -8M -17M -15M 3M -15M
ebitdaratio 0.083 -0.053 -0.110 -0.119 0.024 -0.141
operatingIncome 9M -13M -17M -19M 3M -17M
operatingIncomeRatio 0.048 -0.088 -0.110 -0.152 0.020 -0.157
totalOtherIncomeExpensesNet 73 000 -224 000 5M 4M 569 000 593 000
incomeBeforeTax 15M -8M -12M -15M 3M -17M
incomeBeforeTaxRatio 0.079 -0.053 -0.078 -0.119 0.024 -0.152
incomeTaxExpense 477 000 340 000 214 000 216 000 125 000 246 000
netIncome 15M -9M -12M -15M 3M -17M
netIncomeRatio 0.077 -0.056 -0.079 -0.121 0.023 -0.154
eps 0.500 -0.290 -0.410 -0.530 0.110 -0.600
epsdiluted 0.490 -0.290 -0.410 -0.530 0.100 -0.600
weightedAverageShsOut 30M 29M 29M 29M 29M 28M
weightedAverageShsOutDil 30M 29M 29M 29M 30M 28M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-09 2023-11-07 2023-08-01 2023-05-02 2023-02-10 2022-11-01
acceptedDate 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 186M 330M 467M 442M 442M 418M
shortTermInvestments 275M 134M 0 10M 10M 10M
cashAndShortTermInvestments 460M 464M 467M 452M 451M 428M
netReceivables 90M 71M 64M 60M 61M 48M
inventory 34M 26M 21M 16M 12M 15M
otherCurrentAssets 10M 8M 9M 6M 6M 4M
totalCurrentAssets 594M 570M 560M 534M 530M 496M
propertyPlantEquipmentNet 63M 55M 47M 28M 24M 21M
goodwill 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0
longTermInvestments 9M 3M 0 0 0 0
taxAssets 0 0 0 0 0 0
otherNonCurrentAssets 11M 12M 12M 11M 11M 11M
totalNonCurrentAssets 83M 70M 58M 38M 35M 32M
otherAssets 0 0 0 0 0 0
totalAssets 677M 639M 618M 572M 565M 528M
accountPayables 39M 40M 40M 36M 27M 20M
shortTermDebt 0 0 1M 1M 1M 1M
taxPayables 0 0 0 0 0 0
deferredRevenue 0 0 -1M 0 0 0
otherCurrentLiabilities 39M 30M 27M 22M 33M 28M
totalCurrentLiabilities 78M 70M 67M 60M 61M 49M
longTermDebt 25M 25M 22M 7M 8M 8M
deferredRevenueNonCurrent 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0
otherNonCurrentLiabilities 1M 146 000 146 000 146 000 146 000 -14M
totalNonCurrentLiabilities 26M 25M 22M 7M 8M 8M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 25M 25M 23M 7M 8M 9M
totalLiabilities 104M 95M 89M 67M 69M 57M
preferredStock 916M 0 0 0 0 0
commonStock 30 000 29 000 29 000 29 000 29 000 29 000
retainedEarnings -345M -360M -352M -340M -324M -327M
accumulatedOtherComprehensiveIncomeLoss 800 000 44 000 103 000 32 000 -86 000 -363 000
othertotalStockholdersEquity 800 000 904M 881M 844M 820M 798M
totalStockholdersEquity 573M 544M 529M 505M 496M 470M
totalEquity 573M 544M 529M 505M 496M 470M
totalLiabilitiesAndStockholdersEquity 677M 639M 618M 572M 565M 528M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 677M 639M 618M 572M 565M 528M
totalInvestments 284M 137M 0 10M 10M 10M
totalDebt 25M 25M 23M 7M 9M 9M
netDebt -161M -305M -444M -435M -433M -409M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol INSP INSP INSP INSP INSP INSP
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-09 2023-11-07 2023-08-01 2023-05-02 2023-02-10 2022-11-01
acceptedDate 2024-02-09 16:02:04 2023-11-07 16:27:48 2023-08-01 16:14:05 2023-05-02 16:06:25 2023-02-10 16:15:32 2022-11-01 16:10:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 15M -9M -12M -15M 3M -17M
depreciationAndAmortization 817 000 777 000 659 000 593 000 569 000 513 000
deferredIncomeTax -2M -6M 0 0 0 0
stockBasedCompensation 23M 20M 22M 18M 15M 15M
changeInWorkingCapital -20M -9M -6M -5M 200 000 13M
accountsReceivables -19M -8M -5M 1M -13M -8M
inventory -8M -5M -5M -4M 3M 7M
accountsPayables -2M -707 000 3M 8M 6M 5M
otherWorkingCapital 8M 5M -92 000 -6M 4M 10M
otherNonCashItems 1M 7M 1M 354 000 349 000 -268 000
netCashProvidedByOperatingActivities 17M 4M 5M -1M 19M 11M
investmentsInPropertyPlantAndEquipment -8M -7M -5M -4M -3M -4M
acquisitionsNet 144M 0 0 0 0 0
purchasesOfInvestments -144M -137M -250 000 0 0 -250 000
salesMaturitiesOfInvestments 246 000 0 0 0 0 0
otherInvestingActivites -144M -137M 10M 0 0 0
netCashUsedForInvestingActivites -152M -144M 5M -4M -3M -4M
debtRepayment 0 0 0 0 -25M -21M
commonStockIssued 4M 4M 0 7M 12M 0
commonStockRepurchased -14M -516 000 0 0 4M 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites -14M -516 000 15M -2M 16M 246M
netCashUsedProvidedByFinancingActivities -10M 4M 15M 6M 7M 224M
effectOfForexChangesOnCash 211 000 -51 000 -2000.000 6000.000 176 000 -127 000
netChangeInCash -144M -137M 25M 540 000 24M 231M
cashAtEndOfPeriod 186M 330M 467M 442M 442M 418M
cashAtBeginningOfPeriod 330M 467M 442M 442M 418M 187M
operatingCashFlow 17M 4M 5M -1M 19M 11M
capitalExpenditure -8M -7M -5M -4M -3M -4M
freeCashFlow 9M -3M 237 000 -5M 16M 7M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-06 ET (fiscal 2023 q4)
2023 q3
2023-11-08 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-07 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-06 21:02 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
2024-02-05 13:00 ET
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer
2024-01-26 13:00 ET
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. to Retire from its Board after Sixteen Years of Service
2024-01-09 13:00 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 6, 2024
2024-01-08 13:00 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2023 and Provides Initial 2024 Guidance
2023-12-28 13:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
2023-12-23 03:03 ET
Saxena White P.A. Files New Securities Fraud Class Action Against Inspire Medical Systems, Inc.
2023-12-18 13:00 ET
Inspire Medical Systems, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-14 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-07 21:03 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 Outlook
2023-11-01 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2023 Healthcare Conference
2023-10-23 12:00 ET
Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors
2023-10-03 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023
2023-09-26 12:00 ET
Inspire Medical Systems, Inc. Announces Events at International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
2023-08-23 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2023 Healthcare Conference
2023-08-01 20:02 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2023 Financial Results and Updates 2023 Outlook
2023-07-31 12:00 ET
Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D. as Chief Medical Officer
2023-07-24 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Carlton Weatherby as Chief Strategy Officer
2023-07-05 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023
2023-06-09 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval for Apnea Hypopnea Index Indication Expansion and Increased Body Mass Index Labeling
2023-06-05 12:00 ET
Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies
2023-05-16 12:00 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series
2023-05-03 12:00 ET
Inspire Medical Systems, Inc. to Present at the RBC Capital Markets 2023 Global Healthcare Conference
2023-05-03 12:00 ET
UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
2023-05-02 20:02 ET
Inspire Medical Systems, Inc. Announces First Quarter 2023 Financial Results and Updates 2023 Outlook
2023-04-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
2023-04-04 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023
2023-03-21 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome
2023-03-09 21:02 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
2023-03-09 21:02 ET
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
2023-03-07 13:00 ET
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
2023-02-07 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
2023-01-10 13:00 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023
2023-01-09 13:00 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
2022-12-21 13:00 ET
Inspire Medical Systems, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-20 13:00 ET
Inspire Medical Systems, Inc. Publishes Inaugural ESG Summary Report
2022-11-16 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference
2022-11-02 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference
2022-11-01 20:02 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2022 Financial Results and Updates 2022 Outlook
2022-10-04 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022
2022-09-14 12:00 ET
Inspire Medical Systems, Inc. Announces Updates from International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings
2022-08-25 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference
2022-08-15 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Ezgi Yagci as Vice President of Investor Relations
2022-08-12 01:41 ET
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock
2022-08-11 20:35 ET
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
2022-08-02 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2022 Financial Results and Updates 2022 Outlook
2022-08-01 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Two New Independent Directors to its Board
2022-07-06 12:00 ET
Inspire Medical Systems, Inc. Announces FDA Approval of Expanded, Full-Body MRI Compatibility with Inspire Therapy
2022-07-05 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022
2022-06-06 12:00 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
2022-05-25 12:00 ET
Inspire Medical Systems, Inc. Announces Events at SLEEP 2022, the 36th Annual Meeting of the Associated Professional Sleep Societies
2022-05-11 12:00 ET
Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
2022-05-03 20:05 ET
Inspire Medical Systems, Inc. Announces First Quarter 2022 Financial Results and Updates 2022 Outlook
2022-04-27 21:20 ET
Inspire Medical Systems, Inc. Announces Investments in EnsoData and Ognomy
2022-04-27 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2022 Healthcare Conference
2022-04-05 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2022 Financial Results on May 3, 2022
2022-02-08 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Guidance
2022-02-07 13:00 ET
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series
2022-02-02 13:00 ET
Inspire Medical Systems, Inc. to Present at the 11th Annual SVB Leerink Global Healthcare Conference
2022-01-05 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2021 Financial Results on February 8, 2022
2022-01-04 21:05 ET
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2021
2022-01-03 21:05 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs Healthcare CEO Conference 2022
2021-12-22 13:00 ET
Inspire Medical Systems, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-11-17 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Conference
2021-11-10 21:28 ET
Inspire Medical Systems, Inc. Provides Update on 2022 Ambulatory Surgical Center Reimbursement Levels
2021-11-02 20:05 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2021 Financial Results and Updates 2021 Outlook
2021-11-02 12:00 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2021 Virtual Healthcare Conference
2021-10-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the Credit Suisse 30th Annual Healthcare Conference
2021-10-05 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2021 Financial Results on November 2, 2021
2021-09-15 20:05 ET
Inspire Medical Systems, Inc. Announces Quality Week and Launch of the Patient Experience Report
2021-08-30 22:36 ET
Inspire Medical Systems, Inc. Announces Recommendation by Medicare Panel to Increase Payments for Inspire Therapy to Ambulatory Surgical Centers
2021-08-26 12:00 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021-08-03 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2021 Financial Results and Updates 2021 Outlook
2021-07-06 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2021 Financial Results on August 3, 2021
2021-05-25 12:00 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
2021-05-20 21:34 ET
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy
2021-05-04 20:12 ET
Inspire Medical Systems, Inc. Announces First Quarter 2021 Financial Results and Updates 2021 Outlook
2021-04-28 12:00 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
2021-04-26 06:05 ET
Inspire Medical Systems, Inc. Announces Exclusive Distribution Agreement with Japan Lifeline Co., Ltd to Commercialize Inspire Therapy in Japan
2021-04-06 12:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2021 Financial Results on May 4, 2021
2021-03-31 20:11 ET
Inspire Medical Systems, Inc. Announces FDA Approval and Commercial Launch of New Physician Programmer Platform
2021-03-15 20:05 ET
Inspire Medical Systems, Inc. Announces FDA Approval of Two-Incision Implant Procedure
2021-02-23 21:05 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Guidance
2021-02-11 13:00 ET
Inspire Medical Systems, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference
2021-01-20 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2020 Financial Results on February 23, 2021
2021-01-19 21:05 ET
Inspire Medical Systems, Inc. Announces Appointment of Bryan Phillips as General Counsel
2020-12-22 13:00 ET
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-11-18 13:00 ET
Inspire Medical Systems, Inc. to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-10 13:00 ET
Inspire Medical Systems, Inc. to Present at the 2020 Stifel Virtual Healthcare Conference
2020-11-09 21:05 ET
Inspire Medical Systems, Inc. Announces Full Integration of Inspire Therapy into German DRG Reimbursement System to Begin in 2021
2020-11-02 21:05 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2020 Financial Results and Updates 2020 Outlook
2020-10-27 20:05 ET
Inspire Medical Systems, Inc. to Present at the Credit Suisse 29th Annual Healthcare Conference
2020-10-22 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Senior Corporate Executive Shelley Broader to its Board of Directors
2020-09-24 12:00 ET
Inspire Medical Systems, Inc. to Report Third Quarter 2020 Financial Results on November 2, 2020
2020-09-02 20:05 ET
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2020 Virtual Healthcare Conference
2020-09-01 11:00 ET
Inspire Medical Systems, Inc. Announces Humana Coverage for Inspire Therapy
2020-08-17 20:05 ET
Inspire Medical Systems, Inc. Announces Two Additional Coverage Policies from Blue Cross Blue Shield Healthcare Plans
2020-08-12 20:05 ET
Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy in Australia
2020-08-04 20:05 ET
Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial Results and Updates 2020 Outlook
2020-07-09 20:05 ET
Inspire Medical Systems, Inc. Announces Appointment of Veteran Consumer Marketing Executive Georgia Garinois-Melenikiotou to its Board of Directors
2020-07-07 12:00 ET
Inspire Medical Systems, Inc. to Report Second Quarter 2020 Financial Results on August 4, 2020
2020-06-16 20:05 ET
Inspire Medical Systems, Inc. Announces Cigna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
2020-06-08 12:00 ET
Inspire Medical Systems, Inc. Announces Appointment of Medical Technology Industry Veteran Phil Ebeling as Chief Operating Officer
2020-06-03 20:05 ET
Inspire Medical Systems, Inc. Introduces Digital Health Tools with Launch of New App
2020-06-01 20:05 ET
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-11 11:00 ET
Inspire Medical Systems, Inc. Announces Medicare Policy Release Date of Local Coverage Determination for Sole Remaining Region
2020-05-06 20:05 ET
Inspire Medical Systems, Inc. to Present at the UBS Global Healthcare Conference
2020-05-05 20:10 ET
Inspire Medical Systems, Inc. Announces First Quarter 2020 Financial Results
2020-04-30 20:05 ET
Inspire Medical Systems, Inc. to Present at the BofA Securities Virtual Health Care Conference 2020
2020-04-28 11:00 ET
Inspire Medical Systems, Inc. to Report First Quarter 2020 Financial Results on May 5, 2020
2020-04-21 11:00 ET
Inspire Medical Systems Announces FDA Approval of Expanded Age Range for Inspire Therapy
2020-04-16 20:05 ET
Inspire Medical Systems, Inc. Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2020-04-14 01:27 ET
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock
2020-04-13 20:19 ET
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
2020-04-13 20:01 ET
Inspire Medical Systems, Inc. Provides First Quarter and Full Year 2020 Update
2020-02-25 21:15 ET
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results and Provides 2020 Guidance
2020-02-12 21:05 ET
Inspire Medical Systems, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
2020-02-03 21:22 ET
Inspire Medical Systems, Inc. Announces Medicare Policy Release Dates and New Draft Local Coverage Determination for Remaining Region
2020-01-28 21:05 ET
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2019 Financial Results on February 25, 2020
2020-01-07 21:05 ET
Inspire Medical Systems, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-11-20 21:05 ET
Inspire Medical Systems, Inc. to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-06 21:15 ET
Inspire Medical Systems, Inc. to Present at the Stifel 2019 Healthcare Conference
2019-11-05 21:10 ET
Inspire Medical Systems, Inc. Announces Third Quarter 2019 Financial Results and Increases 2019 Outlook

SEC forms

Show financial reports only

SEC form 10
2024-02-09 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Inspire Medical Systems published news for 2023 q4
SEC form 10
2023-11-07 16:27 ET
Inspire Medical Systems published news for 2023 q3
SEC form 8
2023-11-07 16:04 ET
Inspire Medical Systems reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Inspire Medical Systems published news for 2023 q3
SEC form 6
2023-08-02 16:04 ET
Inspire Medical Systems published news for 2023 q2
SEC form 6
2023-08-01 16:57 ET
Inspire Medical Systems published news for 2023 q2
SEC form 10
2023-08-01 16:14 ET
Inspire Medical Systems reported for 2023 q2
SEC form 6
2023-08-01 16:08 ET
Inspire Medical Systems published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
Inspire Medical Systems published news for 2023 q2
SEC form 8
2023-08-01 00:00 ET
Inspire Medical Systems published news for 2023 q2
SEC form 8
2023-05-02 00:00 ET
Inspire Medical Systems reported for 2023 q1
SEC form 10
2023-05-02 00:00 ET
Inspire Medical Systems published news for 2023 q1
SEC form 10
2023-02-10 16:15 ET
Inspire Medical Systems reported for 2022 q4
SEC form 10
2023-02-10 00:00 ET
Inspire Medical Systems reported for 2022 q4
SEC form 6
2023-02-07 17:17 ET
Inspire Medical Systems published news for 2022 q4
SEC form 6
2023-02-07 16:05 ET
Inspire Medical Systems published news for 2022 q4
SEC form 8
2023-02-07 00:00 ET
Inspire Medical Systems reported for 2022 q4
SEC form 6
2023-01-09 08:14 ET
Inspire Medical Systems published news for 2022 q4
SEC form 6
2023-01-09 08:03 ET
Inspire Medical Systems published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Inspire Medical Systems published news for 2022 q4
SEC form 10
2022-11-01 16:10 ET
Inspire Medical Systems reported for 2022 q3
SEC form 6
2022-11-01 16:04 ET
Inspire Medical Systems published news for 2022 q3
SEC form 8
2022-11-01 00:00 ET
Inspire Medical Systems reported for 2022 q3
SEC form 10
2022-11-01 00:00 ET
Inspire Medical Systems reported for 2022 q3
SEC form 6
2022-08-24 16:16 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-15 16:16 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-04 19:37 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-08-03 18:29 ET
Inspire Medical Systems published news for 2022 q2
SEC form 10
2022-08-02 16:10 ET
Inspire Medical Systems reported for 2022 q2
SEC form 6
2022-08-02 16:05 ET
Inspire Medical Systems published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Inspire Medical Systems reported for 2022 q2
SEC form 10
2022-08-02 00:00 ET
Inspire Medical Systems reported for 2022 q2
SEC form 6
2022-08-01 19:20 ET
Inspire Medical Systems published news for 2022 q2
SEC form 6
2022-06-22 16:03 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-06-08 19:41 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-06-02 20:23 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:50 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:46 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-10 20:44 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-03 21:40 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-05-03 16:08 ET
Inspire Medical Systems published news for 2022 q1
SEC form 10
2022-05-03 16:08 ET
Inspire Medical Systems reported for 2022 q1
SEC form 6
2022-05-03 16:06 ET
Inspire Medical Systems published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Inspire Medical Systems reported for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Inspire Medical Systems reported for 2022 q1
SEC form 6
2022-04-12 20:47 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:46 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:45 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-04-12 20:44 ET
Inspire Medical Systems published news for 2022 q1
SEC form 6
2022-03-29 20:24 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-03-16 16:31 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:34 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:33 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:32 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:32 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:31 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-15 16:30 ET
Inspire Medical Systems published news for 2021 q4
SEC form 10
2022-02-15 16:07 ET
Inspire Medical Systems published news for 2021 q4
SEC form 10
2022-02-15 00:00 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-10 16:03 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-02-08 16:08 ET
Inspire Medical Systems published news for 2021 q4
SEC form 8
2022-02-08 00:00 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-01-04 16:43 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2022-01-04 16:07 ET
Inspire Medical Systems published news for 2021 q4
SEC form 6
2021-11-03 17:12 ET
Inspire Medical Systems published news for 2021 q3
SEC form 10
2021-11-02 16:16 ET
Inspire Medical Systems published news for 2021 q3
SEC form 6
2021-11-02 16:12 ET
Inspire Medical Systems published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Inspire Medical Systems published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Inspire Medical Systems published news for 2021 q3
SEC form 6
2021-08-03 19:21 ET
Inspire Medical Systems published news for 2021 q2
SEC form 10
2021-08-03 16:08 ET
Inspire Medical Systems published news for 2021 q2
SEC form 6
2021-08-03 16:03 ET
Inspire Medical Systems published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
Inspire Medical Systems published news for 2021 q2
SEC form 10
2021-08-03 00:00 ET
Inspire Medical Systems published news for 2021 q2
SEC form 6
2021-06-07 07:08 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-20 17:51 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 21:55 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 16:25 ET
Inspire Medical Systems published news for 2021 q1
SEC form 10
2021-05-04 16:14 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-05-04 16:06 ET
Inspire Medical Systems published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Inspire Medical Systems published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Inspire Medical Systems published news for 2021 q1
SEC form 6
2021-03-16 16:30 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-02-23 19:39 ET
Inspire Medical Systems published news for 2020 q4
SEC form 10
2021-02-23 18:22 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-02-23 16:03 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-01-27 16:16 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2021-01-07 16:08 ET
Inspire Medical Systems published news for 2020 q4
SEC form 6
2020-11-09 16:36 ET
Inspire Medical Systems published news for 2020 q3
SEC form 10
2020-11-02 16:09 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-11-02 16:05 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-10-22 16:15 ET
Inspire Medical Systems published news for 2020 q3
SEC form 6
2020-10-22 16:15 ET
Inspire Medical Systems published news for 2020 q3